Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

North America Active Pharmaceutical Ingredients Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The North America active pharmaceutical ingredients market reached a value of US$ 72.7 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 6.2% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.

Active pharmaceutical ingredient (API) refers to the biologically/synthetic active component of a finished pharmaceutical product. Chemical synthesis, recombinant DNA, fermentation, isolation and recovery from natural sources are some of the common processes opted for API production. API in a drug is precisely used for curing, diagnosis, mitigation or prevention of human health issues. In addition to this, it has direct effect in restoring, correcting or modifying physiological functions of the body. On account of this, API has wide applications in the pharmaceuticals industry pertaining to oncology, central nervous system disorders, diabetes, neurological disorders, cardiovascular, respiratory disorders, etc.

The North American active pharmaceutical ingredients market is currently being driven by several factors. Predominantly, the rising geriatric population and escalated exposure to chronic diseases such as cancer and diabetes have escalated the API demand in the region. Apart from this, the US Government has increased the overall healthcare expenditure propelling the market growth. Pharmaceutical manufacturers have increased the investments in R&D for the development of better-quality APIs since it has a direct effect on the safety and efficacy of the drug. Moreover, technological advancements of new generation of APIs also represent an important factor driving the market growth in the region. 

IMARC Group’s latest report  provides a deep insight into the North America active pharmaceutical ingredients market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the North America active pharmaceutical ingredients market in any manner.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the North America active pharmaceutical ingredients market report, along with forecasts for growth at the regional and country level from 2021-2026. Our report has categorized the market based on drug type, manufacturer type, synthesis type and therapeutic application.

  • North America Active Pharmaceutical Ingredients Market
     
  • Key Regions Analyzed
    • United States
    • Canada
    • Mexico
       
  • Analysis for Each Country
  • Market by Drug Type
    • Innovative Active Pharmaceutical Ingredients
    • Generic Active Pharmaceutical Ingredients
       
  • Market by Manufacturer Type
    • Captive Manufacturers
    • Merchant API Manufacturers
      • Innovative Merchant API Manufacturers
      • Generic Merchant API Manufacturers
         
  • Market by Synthesis Type
    • Synthetic Active Pharmaceutical Ingredients
      • Innovative Synthetic APIs
      • Generic Synthetic APIs
    • Biotech Active Pharmaceutical Ingredients
      • Market by Drug Type
        • Innovative Biotech APIs
        • Biosimilars
      • Market by Product Type
        • Monoclonal Antibodies
        • Vaccines
        • Cytokines
        • Others
      • Market by Expression System Type
        • Mammalian Expression System
        • Microbial Expression System
        • Yeast Expression System
        • Others
           
  • Market by Therapeutic Application
    • Oncology
    • Cardiovascular and Respiratory
    • Diabetes
    • Central Nervous System Disorders
    • Neurological Disorders
    • Others

       
  • Value Chain Analysis
  • Key Drivers and Challenges
  • Porters Five Forces Analysis
  • PESTEL Analysis
  • Government Regulations
  • Competitive Landscape
    • Competitive Structure
    • Key Player Profiles
       

Report Coverage:

Report Features Details
Base Year of the Analysis 2020
Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Drug Type, Manufacturer Type, Synthesis Type, Therapeutic Application, Country
Countries Covered United States, Canada, Mexico
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License $ 2499
Five User License $ 3499
Corporate License $ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the North America active pharmaceutical ingredients market performed so far and how will it perform in the coming years?
  • What are the key regions in the North America active pharmaceutical ingredients market?
  • What has been the impact of  COVID-19 on the North America active pharmaceutical ingredients market?
  • What is the breakup of the North America active pharmaceutical ingredients market on the basis of drug type?
  • What is the breakup of the North America active pharmaceutical ingredients market on the basis of manufacturer type?
  • What is the breakup of the North America active pharmaceutical ingredients market on the basis of synthesis type?
  • What is the breakup of the North America active pharmaceutical ingredients market on the basis product and expression system type?
  • What is the breakup of the North America active pharmaceutical ingredients market on the basis of therapeutic application?
  • What are the various stages in the value chain of the North America active pharmaceutical ingredients industry?
  • What are the key driving factors and challenges in the North America active pharmaceutical ingredients industry?
  • What is the structure of the North America active pharmaceutical ingredients industry and who are the key players?
  • What is the degree of competition in the North America active pharmaceutical ingredients industry?
  • What are the profit margins in the North America active pharmaceutical ingredients industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Active Pharmaceutical Ingredients Market
    5.1    Market Performance
    5.2    Market Breakup by Drug Type
    5.3    Market Breakup by Manufacturer Type
    5.4    Market Breakup by Synthesis Type  
    5.5    Market Breakup by Therapeutic Application  
    5.6    Market Breakup by Region 
    5.7    Market Forecast 
6    North America Active Pharmaceutical Ingredients Market
    6.1    Market Performance
    6.2    Impact of COVID-19
    6.3    Market Forecast 
7    North America Active Pharmaceutical Ingredients Market: Breakup by Drug Type 
    7.1    Innovative Active Pharmaceutical Ingredients
    7.2    Generic Active Pharmaceutical Ingredients
8    North America Active Pharmaceutical Ingredients Market: Breakup by Manufacturer Type
    8.1    Captive Manufacturers
    8.2    Merchant API Manufacturers
         8.2.1    Innovative Merchant API Manufacturers
         8.2.2    Generic Merchant API Manufacturers
9    North America Active Pharmaceutical Ingredients Market: Breakup by Synthesis Type
    9.1   Synthetic Active Pharmaceutical Ingredients
         9.1.1    Innovative Synthetic APIs
         9.1.2    Generic Synthetic APIs
    9.2   Biotech Active Pharmaceutical Ingredients
         9.2.1    Innovative Biotech APIs
         9.2.2    Biosimilars
10    North America Biotech Active Pharmaceutical Ingredients Market: Breakup by Product and Expression System Type
 10.1   Product Type
     10.1.1    Monoclonal Antibodies
     10.1.2    Vaccines
     10.1.3    Cytokines
     10.1.4    Others
 10.2   Expression System Type
     10.2.1    Mammalian Expression System
     10.2.2    Microbial Expression System
     10.2.3    Yeast Expression System
     10.2.4    Others
11    North America Active Pharmaceutical Ingredients Market: Breakup by Therapeutic Application
    11.1   Oncology
    11.2   Cardiovascular and Respiratory
    11.3   Diabetes
    11.4   Central Nervous System Disorders
    11.5   Neurological Disorders
    11.6   Others
12    North America Active Pharmaceutical Ingredients Market: Breakup by Country 
    12.1   United States
     12.1.1    Historical Market Trends
     12.1.2    Market Breakup by Drug Type
     12.1.3    Market Breakup by Manufacturer Type
     12.1.4    Market Breakup by Synthesis Type  
     12.1.5    Biotech API Market Breakup by Product Type
     12.1.6    Biotech API Market Breakup by Expression System Type
     12.1.7    Market Breakup by Therapeutic Application
     12.1.8    Market Forecast
    12.2   Canada
     12.2.1    Historical Market Trends
     12.2.2    Market Breakup by Drug Type
     12.2.3    Market Breakup by Manufacturer Type
     12.2.4    Market Breakup by Synthesis Type  
     12.2.5    Biotech API Market Breakup by Product Type
     12.2.6    Biotech API Market Breakup by Expression System Type
     12.2.7    Market Breakup by Therapeutic Application
     12.2.8    Market Forecast
    12.3   Mexico
     12.3.1    Historical Market Trends
     12.3.2    Market Breakup by Drug Type
     12.3.3    Market Breakup by Manufacturer Type
     12.3.4    Market Breakup by Synthesis Type  
     12.3.5    Biotech API Market Breakup by Product Type
     12.3.6    Biotech API Market Breakup by Expression System Type
     12.3.7    Market Breakup by Therapeutic Application
     12.3.8    Market Forecast
13    SWOT Analysis 
    13.1    Overview 
    13.2    Strengths
    13.3    Weaknesses 
    13.4    Opportunities
    13.5    Threats
14    Value Chain Analysis 
15    Porter’s Five Forces Analysis 

    15.1     Overview
    15.2     Bargaining Power of Buyers
    15.3     Bargaining Power of Suppliers
    15.4     Degree of Rivalry
    15.5     Threat of New Entrants
    15.6     Threat of Substitutes
16    Price Analysis 
17    Competitive Landscape

    17.1    Market Structure
    17.2    Key Players
    17.3    Profiles of Key Players

List of Figures

Figure 1: Global: Active Pharmaceutical Ingredients Market: Sales Value (in Billion US$), 2015-2020
Figure 2: Global: Active Pharmaceutical Ingredients Market: Breakup by Drug Type (in %), 2020
Figure 3: Global: Active Pharmaceutical Ingredients Market: Breakup by Manufacturer Type (in %), 2020
Figure 4: Global: Active Pharmaceutical Ingredients Market: Breakup by Synthesis Type (in %), 2020
Figure 5: Global: Active Pharmaceutical Ingredients Market: Breakup by Therapeutic Application (in %), 2020
Figure 6: Global: Active Pharmaceutical Ingredients Market: Breakup by Region (in %), 2020
Figure 7: Global: Active Pharmaceutical Ingredients Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 8: North America: Active Pharmaceutical Ingredients Market: Sales Value (in Billion US$), 2015-2020
Figure 9: North America: Active Pharmaceutical Ingredients Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 10: North America: Active Pharmaceutical Ingredients Industry: SWOT Analysis
Figure 11: North America: Active Pharmaceutical Ingredients Industry: Value Chain Analysis
Figure 12: North America: Active Pharmaceutical Ingredients Industry: Porter’s Five Forces Analysis
Figure 13: North America: Active Pharmaceutical Ingredients Market: Breakup by Drug Type (in %), 2020
Figure 14: North America: Active Pharmaceutical Ingredients (Innovative Active Pharmaceutical Ingredients) Market: Sales Value (in Billion US$), 2015 & 2020
Figure 15: North America: Active Pharmaceutical Ingredients (Innovative Active Pharmaceutical Ingredients) Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 16: North America: Active Pharmaceutical Ingredients (Generic Active Pharmaceutical Ingredients) Market: Sales Value (in Billion US$), 2015 & 2020
Figure 17: North America: Active Pharmaceutical Ingredients (Generic Active Pharmaceutical Ingredients) Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 18: North America: Active Pharmaceutical Ingredients Market: Breakup by Manufacturer Type (in %), 2020
Figure 19: North America: Active Pharmaceutical Ingredients (Captive Manufacturers) Market: Sales Value (in Billion US$), 2015 & 2020
Figure 20: North America: Active Pharmaceutical Ingredients (Captive Manufacturers) Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 21: North America: Active Pharmaceutical Ingredients (Merchant API Manufacturers) Market: Sales Value (in Billion US$), 2015 & 2020
Figure 22: North America: Active Pharmaceutical Ingredients (Merchant API Manufacturers) Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 23: North America: Active Pharmaceutical Ingredients Market: Breakup by Synthesis Type (in %), 2020
Figure 24: North America: Active Pharmaceutical Ingredients (Synthetic Active Pharmaceutical Ingredients) Market: Sales Value (in Billion US$), 2015 & 2020
Figure 25: North America: Active Pharmaceutical Ingredients (Synthetic Active Pharmaceutical Ingredients) Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 26: North America: Active Pharmaceutical Ingredients (Biotech Active Pharmaceutical Ingredients) Market: Sales Value (in Billion US$), 2015 & 2020
Figure 27: North America: Active Pharmaceutical Ingredients (Biotech Active Pharmaceutical Ingredients) Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 28: North America: Biotech Active Pharmaceutical Ingredients Market: Breakup by Product Type (in %), 2020
Figure 29: North America: Biotech Active Pharmaceutical Ingredients (Monoclonal Antibodies) Market: Sales Value (in Billion US$), 2015 & 2020
Figure 30: North America: Biotech Active Pharmaceutical Ingredients (Monoclonal Antibodies) Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 31: North America: Biotech Active Pharmaceutical Ingredients (Vaccines) Market: Sales Value (in Billion US$), 2015 & 2020
Figure 32: North America: Biotech Active Pharmaceutical Ingredients (Vaccines) Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 33: North America: Biotech Active Pharmaceutical Ingredients (Cytokines) Market: Sales Value (in Billion US$), 2015 & 2020
Figure 34: North America: Biotech Active Pharmaceutical Ingredients (Cytokines) Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 35: North America: Biotech Active Pharmaceutical Ingredients (Other Product Types) Market: Sales Value (in Billion US$), 2015 & 2020
Figure 36: North America: Biotech Active Pharmaceutical Ingredients (Other Product Types) Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 37: North America: Biotech Active Pharmaceutical Ingredients Market: Breakup by Expression System Type (in %), 2020
Figure 38: North America: Biotech Active Pharmaceutical Ingredients (Mammalian Expression System) Market: Sales Value (in Billion US$), 2015 & 2020
Figure 39: North America: Biotech Active Pharmaceutical Ingredients (Mammalian Expression System) Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 40: North America: Biotech Active Pharmaceutical Ingredients (Microbial Expression System) Market: Sales Value (in Billion US$), 2015 & 2020
Figure 41: North America: Biotech Active Pharmaceutical Ingredients (Microbial Expression System) Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 42: North America: Biotech Active Pharmaceutical Ingredients (Yeast Expression System) Market: Sales Value (in Billion US$), 2015 & 2020
Figure 43: North America: Biotech Active Pharmaceutical Ingredients (Yeast Expression System) Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 44: North America: Biotech Active Pharmaceutical Ingredients (Other Expression System Types) Market: Sales Value (in Billion US$), 2015 & 2020
Figure 45: North America: Biotech Active Pharmaceutical Ingredients (Other Expression System Types) Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 46: North America: Active Pharmaceutical Ingredients Market: Breakup by Therapeutic Application (in %), 2020
Figure 47: North America: Active Pharmaceutical Ingredients (Oncology) Market: Sales Value (in Billion US$), 2015 & 2020
Figure 48: North America: Active Pharmaceutical Ingredients (Oncology) Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 49: North America: Active Pharmaceutical Ingredients (Cardiovascular and Respiratory) Market: Sales Value (in Billion US$), 2015 & 2020
Figure 50: North America: Active Pharmaceutical Ingredients (Cardiovascular and Respiratory) Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 51: North America: Active Pharmaceutical Ingredients (Diabetes) Market: Sales Value (in Billion US$), 2015 & 2020
Figure 52: North America: Active Pharmaceutical Ingredients (Diabetes) Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 53: North America: Active Pharmaceutical Ingredients (Central Nervous System Disorders) Market: Sales Value (in Billion US$), 2015 & 2020
Figure 54: North America: Active Pharmaceutical Ingredients (Central Nervous System Disorders) Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 55: North America: Active Pharmaceutical Ingredients (Neurological Disorders) Market: Sales Value (in Billion US$), 2015 & 2020
Figure 56: North America: Active Pharmaceutical Ingredients (Neurological Disorders) Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 57: North America: Active Pharmaceutical Ingredients (Other Therapeutic Applications) Market: Sales Value (in Billion US$), 2015 & 2020
Figure 58: North America: Active Pharmaceutical Ingredients (Other Therapeutic Applications) Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 59: United States: Active Pharmaceutical Ingredients Market: Sales Value (in Billion US$), 2015-2020
Figure 60: United States: Active Pharmaceutical Ingredients Market: Breakup by Drug Type (in %), 2020
Figure 61: United States: Active Pharmaceutical Ingredients Market: Breakup by Manufacturer Type (in %), 2020
Figure 62: United States: Active Pharmaceutical Ingredients Market: Breakup by Synthesis Type (in %), 2020
Figure 63: United States: Biotech Active Pharmaceutical Ingredients Market: Breakup by Product Type (in %), 2020
Figure 64: United States: Biotech Active Pharmaceutical Ingredients Market: Breakup by Expression System Type (in %), 2020
Figure 65: United States: Active Pharmaceutical Ingredients Market: Breakup by Therapeutic Application (in %), 2020
Figure 66: United States: Active Pharmaceutical Ingredients Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 67: Canada: Active Pharmaceutical Ingredients Market: Sales Value (in Billion US$), 2015-2020
Figure 68: Canada: Active Pharmaceutical Ingredients Market: Breakup by Drug Type (in %), 2020
Figure 69: Canada: Active Pharmaceutical Ingredients Market: Breakup by Manufacturer Type (in %), 2020
Figure 70: Canada: Active Pharmaceutical Ingredients Market: Breakup by Synthesis Type (in %), 2020
Figure 71: Canada: Biotech Active Pharmaceutical Ingredients Market: Breakup by Product Type (in %), 2020
Figure 72: Canada: Biotech Active Pharmaceutical Ingredients Market: Breakup by Expression System Type (in %), 2020
Figure 73: Canada: Active Pharmaceutical Ingredients Market: Breakup by Therapeutic Application (in %), 2020
Figure 74: Canada: Active Pharmaceutical Ingredients Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 75: Mexico: Active Pharmaceutical Ingredients Market: Sales Value (in Billion US$), 2015-2020
Figure 76: Mexico: Active Pharmaceutical Ingredients Market: Breakup by Drug Type (in %), 2020
Figure 77: Mexico: Active Pharmaceutical Ingredients Market: Breakup by Manufacturer Type (in %), 2020
Figure 78: Mexico: Active Pharmaceutical Ingredients Market: Breakup by Synthesis Type (in %), 2020
Figure 79: Mexico: Biotech Active Pharmaceutical Ingredients Market: Breakup by Product Type (in %), 2020
Figure 80: Mexico: Biotech Active Pharmaceutical Ingredients Market: Breakup by Expression System Type (in %), 2020
Figure 81: Mexico: Active Pharmaceutical Ingredients Market: Breakup by Therapeutic Application (in %), 2020
Figure 82: Mexico: Active Pharmaceutical Ingredients Market Forecast: Sales Value (in Billion US$), 2021-2026

List of Tables

Table 1: North America: Active Pharmaceutical Ingredients Market: Key Industry Highlights, 2020 and 2026
Table 2: North America: Active Pharmaceutical Ingredients Market Forecast: Breakup by Drug Type (in Billion US$), 2021-2026
Table 3: North America: Active Pharmaceutical Ingredients Market Forecast: Breakup by Manufacturer Type (in Billion US$), 2021-2026
Table 4: North America: Active Pharmaceutical Ingredients Market Forecast: Breakup by Synthesis Type (in Billion US$), 2021-2026
Table 5: North America: Biotech Active Pharmaceutical Ingredients Market Forecast: Breakup by Product Type (in Billion US$), 2021-2026
Table 6: North America: Biotech Active Pharmaceutical Ingredients Market Forecast: Breakup by Expression System Type (in Billion US$), 2021-2026
Table 7: North America: Active Pharmaceutical Ingredients Market Forecast: Breakup by Therapeutic Application (in Billion US$), 2021-2026
Table 8: North America: Active Pharmaceutical Ingredients Market Forecast: Breakup by Country (in Billion US$), 2021-2026
Table 9: North America: Active Pharmaceutical Ingredients Market: Competitive Structure
Table 10: North America: Active Pharmaceutical Ingredients Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links